NCT00068419View on ClinicalTrials.gov

Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

April 26, 2010

Study Completion Date

April 26, 2010

Conditions
Desmoid Tumor
Interventions
DRUG

tamoxifen citrate

Given orally

DRUG

sulindac

Given orally

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

91016

Children's Oncology Group, Monrovia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00068419 - Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor | Biotech Hunter | Biotech Hunter